Not applicableWithdrawnNCT04082468What this trial is testingVALIDATE: Factor VIII Trending for MS RelapseWho this might be right forMultiple Sclerosis St. Joseph's Hospital and Medical Center, Phoenix
Testing effectiveness (Phase 2)WithdrawnNCT05571540What this trial is testingAnti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALLWho this might be right forB-cell Acute Lymphoblastic LeukemiaB-ALL Kunming Hope of Health Hospital
Early research (Phase 1)Study completedNCT05470140What this trial is testingWU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia Allotera Therapeutics 9
Testing effectiveness (Phase 2)Study completedNCT02210858What this trial is testingTipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative DisordersWho this might be right forAccelerated Phase of DiseaseAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Myelogenous Leukemia, BCR-ABL1 Positive+4 more National Cancer Institute (NCI) 31
Early research (Phase 1)Active Not RecruitingNCT02477878What this trial is testingStudy of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic TransplantWho this might be right forLeukemiaMyelodysplastic SyndromesLymphoma+2 more Bellicum Pharmaceuticals 10
Not applicableNot Yet RecruitingNCT07545889What this trial is testingMulticenter Prospective Study Analyzing the Occurrence of Multiple Sclerosis Relapses Without Radiological Evidence: Myth or Reality?Who this might be right forMultiple SclerosisRRMSMultiple Sclerosis (MS) - Relapsing-remitting University Hospital, Strasbourg, France 136
Post-approval studies (Phase 4)Study completedNCT01842191What this trial is testingEfficacy of Fish Oil in Multiple SclerosisWho this might be right forRelapsing- Remitting Multiple Sclerosis Coordinación de Investigación en Salud, Mexico 50
Post-approval studies (Phase 4)Study completedNCT00288574What this trial is testingFluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia NervosaWho this might be right forAnorexia NervosaEating Disorders New York State Psychiatric Institute 93
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07562568What this trial is testingSHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDSWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMDS+4 more The First Affiliated Hospital of Soochow University 160
Early research (Phase 1)Looking for participantsNCT04910568What this trial is testingA Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Genentech, Inc. 186
Testing effectiveness (Phase 2)Study completedNCT04979650What this trial is testingCorticosteroid Effects on Asymptomatic Gadolinium-enhancing Lesions in Multiple SclerosisWho this might be right forMultiple Sclerosis, Relapsing-RemittingMagnetic Resonance ImagingMethylprednisolone Mazandaran University of Medical Sciences 102
Large-scale testing (Phase 3)UnknownNCT04120090What this trial is testingRuxolitinib as a Salvage Therapy for Hemophagocytic LymphohistiocytosisWho this might be right forHemophagocytic Lymphohistiocytosis Beijing Friendship Hospital 80
Testing effectiveness (Phase 2)Study completedNCT01593410What this trial is testingStudy of Lenalidomide and Low-Dose Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Celgene 194
Early research (Phase 1)Ended earlyNCT04795713What this trial is testingStudy of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1Who this might be right forAdvanced Solid TumorNon-small Cell Lung CancerSquamous Cell Carcinoma of Head and Neck Molecular Templates, Inc. 64
Testing effectiveness (Phase 2)Ended earlyNCT04676360What this trial is testingBelantamab Mafodotin In Plasmablastic Lymphoma & ALK+ Large B-Cell LymphomaWho this might be right forRelapsed Plasmablastic LymphomaRefractory Plasmablastic LymphomaAnaplastic Lymphoma Kinase Positive Large B-Cell Lymphoma Jacob Soumerai, MD 10
Testing effectiveness (Phase 2)Ended earlyNCT06679582What this trial is testingLuveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AMLWho this might be right forAcute Myeloid Leukemia (AML) Sutro Biopharma, Inc. 24
Not applicableStudy completedNCT02671682What this trial is testingImmunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple SclerosisWho this might be right forMultiple SclerosisClinically Isolated Syndrome Albert Christian Ludolph, Prof. 61
Testing effectiveness (Phase 2)Study completedNCT00038623What this trial is testingStudy Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell LymphomaWho this might be right forLymphoma, Mantle-Cell M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT04515238What this trial is testingSequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib (BGB-3111) and Venetoclax (ABT-199) in Patients With Relapsed/Refractory CLLWho this might be right forChronic Lymphoid Leukemia German CLL Study Group 42
Testing effectiveness (Phase 2)Looking for participantsNCT07471789What this trial is testingSafety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).Who this might be right forAcute Myeloblastic LeukaemiaLeukemia, T-Cell Gyala Therapeutics 33